N. Yamashita

发表

Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B

A. Morishita, J. Tani, A. Tsubota, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2022, Alimentary pharmacology & therapeutics.

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

K. Kotoh, E. Kajiwara, N. Yamashita, 2014, Journal of Gastroenterology.

Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C

K. Mimori, K. Sugimachi, H. Higashi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Tumor lysis syndrome after sorafenib for hepatocellular carcinoma

M. Kinjo, E. Kajiwara, N. Yamashita, 2014 .

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

A. Tsubota, T. Ishikawa, Etsuko Iio, 2019, Open forum infectious diseases.

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

H. Nomura, J. Hayashi, K. Kotoh, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study

N. Hotta, T. Okanoue, J. Tani, 2020, Infectious Diseases and Therapy.

Effectiveness of biweekly low‐dosage peginterferon treatment on the improvement of serum alanine aminotransferase and α‐fetoprotein levels

E. Kajiwara, N. Yamashita, Aritune Ooho, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosis.

K. Kotoh, A. Masumoto, M. Nakamuta, 2016, Journal of gastrointestinal oncology.

Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection

T. Masaki, A. Morishita, J. Tani, 2020, Journal of gastroenterology and hepatology.

Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan

J. Tani, A. Tsubota, Etsuko Iio, 2019, Journal of viral hepatitis.

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study

M. Nakamuta, M. Kohjima, Tsuyoshi Yoshimoto, 2022, Medicine.

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma

M. Nakamuta, M. Kohjima, Tsuyoshi Yoshimoto, 2022, Internal medicine.

binder probe assay in patients with chronic hepatitis B Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove

M. Nishimura, M. Asaka, H. Chiba, 2008 .

Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B

M. Nishimura, M. Asaka, H. Chiba, 2008, Annals of clinical biochemistry.

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2021, Hepatology International.

Evaluation of serodiagnosis of toxoplasmosis by using the recombinant nucleoside triphosphate hydrolase isoforms expressed in Escherichia coli.

T. Asai, N. Matsuo, N. Yamashita, 2000, Parasitology international.

Hepatocellular carcinoma manifested as pyogenic liver abscess: A case report

M. Kinjo, E. Kajiwara, N. Yamashita, 2015 .

Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic HCV infection in a real-word setting: a large, multicenter study from Japan.

T. Masaki, T. Okanoue, A. Morishita, 2020, Journal of gastroenterology and hepatology.

Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Immediate virological response predicts the success of short-term peg-interferon monotherapy for chronic hepatitis C.

A. Masumoto, M. Yada, K. Motomura, 2010, World journal of gastroenterology.

Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

K. Kotoh, R. Takayanagi, M. Nakamuta, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[Frequency of gastroesophageal reflux disease (GERD) as a complication in patients with chronic liver diseases: estimation of frequency scale for the system of GERD].

K. Kotoh, R. Takayanagi, M. Nakamuta, 2007, Fukuoka igaku zasshi = Hukuoka acta medica.

Development of hepatocellular carcinoma after seroclearance of hepatitis surface antigen

T. Shimokama, H. Higashi, M. Kinjo, 2011 .

An elderly autoimmune hepatitis patient with a fulminant course

M. Kinjo, E. Kajiwara, N. Yamashita, 2014 .

Investigation of hyperuricemia during pegylated‐interferon‐α2b plus ribavirin combination therapy in patients with chronic hepatitis C

N. Kinukawa, K. Kotoh, R. Takayanagi, 2008, Journal of digestive diseases.

Regorafenib could cause sinusoidal obstruction syndrome.

K. Kotoh, H. Orita, Masaki Kato, 2016, Journal of gastrointestinal oncology.